Intracerebral adrenal medulla grafts: A review
Identifieur interne : 001E96 ( Main/Exploration ); précédent : 001E95; suivant : 001E97Intracerebral adrenal medulla grafts: A review
Auteurs : William Freed ; Maciej Poltorak ; Jill Becker [États-Unis]Source :
- Experimental Neurology [ 0014-4886 ] ; 1990.
Abstract
This review summarizes basic and clinical research on intracerebral adrenal medulla grafts, emphasizing potential applications to Parkinson's disease. Properties of intraventricular and intraparenchymal grafts are described, and cell survival and functional effects are compared. It is clear that adrenal medulla allografts survive poorly in the parenchyma of the corpus striatum and better in the lateral ventricle. Nerve growth factor (NGF) may improve the survival of adrenal medulla grafts. In the absence of added NGF even adrenal medulla grafts in the ventricle survive irregularly, and the factors required for graft survival in the ventricle are not well understood. In the 6-hydroxydopamine-lesioned rat model most evidence suggests, not surprisingly, that adrenal medulla grafts produce functional effects only when they survive. These effects may be related to production of catecholamines by the transplanted cells. In addition, adrenal medulla grafts may produce trophic effects on host brain. These effects are most evident in animals with MPTP-induced damage to dopaminergic systems and may be nonspecific, possibly related in part to the brain injury that is induced by graft implantation. Trophic effects may contribute to the functional effects of adrenal medulla grafts: For intraparenchymal grafts, trophic effects that do not require cell survival may contribute small functional changes, while additional behavioral effects may require substantial chromaffin cell survival. The evidence for direct dopamine-mediated effects as compared to trophic mechanisms of action for these grafts in animal models for Parkinson's disease is presented. Clinical studies of adrenal medulla grafts in human patients are examined and compared in detail. When inspected closely, the various clinical studies are in general agreement on most points, although there are differences in the degree of improvement found, both across different studies and individual patients. It is concluded that some beneficial clinical effects occur, with small to modest changes in most patients and substantial improvement in a minority of patients. There also seem to be larger or more consistent changes in durations of “on” and “off” times in l-dihydroxyphenylalanine-treated patients. There are substantial side effects, and it is not clear that the clinical changes are sufficient to justify performing adrenal medulla transplantation in human patients as a routine procedure. The findings of clinical studies are generally consistent with the predictions that would have been made from animal studies; however, it is not clear whether some of the clinical effects could be nonspecific consequences of lesioning or surgery. Additional basic research would be required to develop a consistently effective clinical procedure. Remaining unanswered questions include the relative contributions of dopamine production and trophic changes to the functional effects of adrenal medulla grafts, the factors required for adrenal medulla graft survival, and the factors responsible for the substantial improvement that has been seen in some patients. The review concludes with a series of recommendations for future basic and clinical research on adrenal medulla transplantation.
Url:
DOI: 10.1016/0014-4886(90)90026-O
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C01
- to stream Istex, to step Curation: 000C01
- to stream Istex, to step Checkpoint: 001925
- to stream Main, to step Merge: 002032
- to stream Main, to step Curation: 001E96
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Intracerebral adrenal medulla grafts: A review</title>
<author><name sortKey="Freed, William J" sort="Freed, William J" uniqKey="Freed W" first="William" last="Freed">William Freed</name>
</author>
<author><name sortKey="Poltorak, Maciej" sort="Poltorak, Maciej" uniqKey="Poltorak M" first="Maciej" last="Poltorak">Maciej Poltorak</name>
</author>
<author><name sortKey="Becker, Jill B" sort="Becker, Jill B" uniqKey="Becker J" first="Jill" last="Becker">Jill Becker</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DBF7238305EA673BFAEB3CAC2379374E9AC79BC7</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1016/0014-4886(90)90026-O</idno>
<idno type="url">https://api.istex.fr/document/DBF7238305EA673BFAEB3CAC2379374E9AC79BC7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C01</idno>
<idno type="wicri:Area/Istex/Curation">000C01</idno>
<idno type="wicri:Area/Istex/Checkpoint">001925</idno>
<idno type="wicri:doubleKey">0014-4886:1990:Freed W:intracerebral:adrenal:medulla</idno>
<idno type="wicri:Area/Main/Merge">002032</idno>
<idno type="wicri:Area/Main/Curation">001E96</idno>
<idno type="wicri:Area/Main/Exploration">001E96</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Intracerebral adrenal medulla grafts: A review</title>
<author><name sortKey="Freed, William J" sort="Freed, William J" uniqKey="Freed W" first="William" last="Freed">William Freed</name>
<affiliation><wicri:noCountry code="subField">D.C. 20032 USA</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Poltorak, Maciej" sort="Poltorak, Maciej" uniqKey="Poltorak M" first="Maciej" last="Poltorak">Maciej Poltorak</name>
<affiliation><wicri:noCountry code="subField">D.C. 20032 USA</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Becker, Jill B" sort="Becker, Jill B" uniqKey="Becker J" first="Jill" last="Becker">Jill Becker</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Department of Psychology, University of Michigan, Ann Arbor</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Neuroscience Program, University of Michigan, Ann Arbor</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Experimental Neurology</title>
<title level="j" type="abbrev">YEXNR</title>
<idno type="ISSN">0014-4886</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">110</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="139">139</biblScope>
<biblScope unit="page" to="166">166</biblScope>
</imprint>
<idno type="ISSN">0014-4886</idno>
</series>
<idno type="istex">DBF7238305EA673BFAEB3CAC2379374E9AC79BC7</idno>
<idno type="DOI">10.1016/0014-4886(90)90026-O</idno>
<idno type="PII">0014-4886(90)90026-O</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0014-4886</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This review summarizes basic and clinical research on intracerebral adrenal medulla grafts, emphasizing potential applications to Parkinson's disease. Properties of intraventricular and intraparenchymal grafts are described, and cell survival and functional effects are compared. It is clear that adrenal medulla allografts survive poorly in the parenchyma of the corpus striatum and better in the lateral ventricle. Nerve growth factor (NGF) may improve the survival of adrenal medulla grafts. In the absence of added NGF even adrenal medulla grafts in the ventricle survive irregularly, and the factors required for graft survival in the ventricle are not well understood. In the 6-hydroxydopamine-lesioned rat model most evidence suggests, not surprisingly, that adrenal medulla grafts produce functional effects only when they survive. These effects may be related to production of catecholamines by the transplanted cells. In addition, adrenal medulla grafts may produce trophic effects on host brain. These effects are most evident in animals with MPTP-induced damage to dopaminergic systems and may be nonspecific, possibly related in part to the brain injury that is induced by graft implantation. Trophic effects may contribute to the functional effects of adrenal medulla grafts: For intraparenchymal grafts, trophic effects that do not require cell survival may contribute small functional changes, while additional behavioral effects may require substantial chromaffin cell survival. The evidence for direct dopamine-mediated effects as compared to trophic mechanisms of action for these grafts in animal models for Parkinson's disease is presented. Clinical studies of adrenal medulla grafts in human patients are examined and compared in detail. When inspected closely, the various clinical studies are in general agreement on most points, although there are differences in the degree of improvement found, both across different studies and individual patients. It is concluded that some beneficial clinical effects occur, with small to modest changes in most patients and substantial improvement in a minority of patients. There also seem to be larger or more consistent changes in durations of “on” and “off” times in l-dihydroxyphenylalanine-treated patients. There are substantial side effects, and it is not clear that the clinical changes are sufficient to justify performing adrenal medulla transplantation in human patients as a routine procedure. The findings of clinical studies are generally consistent with the predictions that would have been made from animal studies; however, it is not clear whether some of the clinical effects could be nonspecific consequences of lesioning or surgery. Additional basic research would be required to develop a consistently effective clinical procedure. Remaining unanswered questions include the relative contributions of dopamine production and trophic changes to the functional effects of adrenal medulla grafts, the factors required for adrenal medulla graft survival, and the factors responsible for the substantial improvement that has been seen in some patients. The review concludes with a series of recommendations for future basic and clinical research on adrenal medulla transplantation.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Michigan</li>
</region>
</list>
<tree><noCountry><name sortKey="Freed, William J" sort="Freed, William J" uniqKey="Freed W" first="William" last="Freed">William Freed</name>
<name sortKey="Poltorak, Maciej" sort="Poltorak, Maciej" uniqKey="Poltorak M" first="Maciej" last="Poltorak">Maciej Poltorak</name>
</noCountry>
<country name="États-Unis"><region name="Michigan"><name sortKey="Becker, Jill B" sort="Becker, Jill B" uniqKey="Becker J" first="Jill" last="Becker">Jill Becker</name>
</region>
<name sortKey="Becker, Jill B" sort="Becker, Jill B" uniqKey="Becker J" first="Jill" last="Becker">Jill Becker</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E96 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E96 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:DBF7238305EA673BFAEB3CAC2379374E9AC79BC7 |texte= Intracerebral adrenal medulla grafts: A review }}
![]() | This area was generated with Dilib version V0.6.19. | ![]() |